Dr Gregory Stock is the Director of the Program on Medicine, Technology and Society at UCLA's School of Medicine. In this role he explores critical technologies poised to have large impacts on humanity's future and the shape of medical science. He makes regular appearances on television and radio, including CNN, PBS, NPR and the BBC and has engaged in numerous high-profile policy debates.

Dr Stock holds a doctorate in Biophysics from John Hopkins University and an MBA from Harvard. He was a fellow at Princeton's prestigious Woodrow Wilson School. In addition to his position at UCLA, he is the CEO of Signum Biosciences, a private biopharmaceutical company, serves on the board of Napo Pharmaceuticals and is the associate director of Berkeley’s Centre for Life Science Policy.

An authority on the genomics revolution and its implications, Gregory Stock is probably the best person to explain to general business audiences the far reaching ramifications of new developments of key technologies, show the complex ways in which they will interact, and explore the economic, political, social and ethical challenges they will bring.

His presentations are a provocative blend of analysis of the world of today and extrapolation into the dizzying, yet not-too-distant future. He explores the challenging implications of recent breakthroughs in biotechnology and molecular biology against a backdrop of accelerating progress in machine intelligence and social networking technologies to show why global culture and economic integration are a robust, positive, but disorienting development that is virtually inevitable.